PPT-Pre- and Post-Exposure Prophylaxis for HIV

Kevin L Ard MD MPH October 20 2016 Learning objectives Summarize the indications for and management of pre and postexposure prophylaxis Understand clinical uncertainties in preexposure prophylaxis management. for HIV PreventionMay 2014Fast Facts Pre-exposure prophylaxis, or PrEP, is a way to help prevent HIV by taking a pill every day. People who are at substantial risk for HIV should talk to their doctor PrEP. ). Yuma Health District 5/23/16. Alyssa Guido, MPH. Program Director, Arizona AETC. Arizona AIDS Education and Training Center. This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under . cephazolin. 2 g IV . (child: 30 mg/kg up to 2 g) . (IF PROCEDURE MORE THAN 4 hours REDOSE REQUIRED). If MRSA risk factors present or re-operation, . ADD. vancomycin. 15 mg/kg IV . (adult and child). Dr.E.Shojaei. Assistant Prof. of Infectious Diseases. T.U.M.S. Patient factors . Environmental factors . Treatment factors . Ascites . Contaminated medications . Emergency procedure . Chronic inflammation . Efficacy and the importance of adherence. Joanne . Stekler. , MD MPH. August 20, 2015. Key HIV . PrEP. Trials Using Oral . Tenofovir. (TDF) or . Tenofovir-Emtricitabine. (TDF-FTC). Study. Study Population. Settings. Ramona Bhatia, MD. Tuberculosis (TB). Epidemiology. Diagnostics and treatment. Prevention and student health issues . Malaria. Epidemiology. Diagnostics and treatment. Prophylaxis for travelling students. Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Attending Physician UCLA Center AIDS Research and Education and Ronald Reagan Medical Center 1of 2PageCreated 9/2019ecommendations for Persons Exposed to MeaslesaIG can be administered intramuscularly IGIM or intravenously IGIV Please check references available at https//wwwcdcgov/measles/ind NURS RESEARCH POROJECT PROPOSA. NURS 503. Name:…………. Ana G Mendez University. Facilitator: Nancy Woelki . DNP, APRN, MSN, RN. Date:………... The purpose of this research was to evaluate the advantage and disadvantage using of PrEP for HIV-negative adults with high risk for HIV.. Dr. Anne Pita Lomole. MBCHB, MMED Pediatrics and Child health, . MSc Infectious Disease, DTMH- EA, Asthma Cert NAEP. SA. OUTLINE. Introduction. Epidemiology. Susceptible . infections per . PID. Antibiotic prophylaxis . Michael Nevill. Director of Nursing, BPAS. NICE Guideline Committee Member. The views expressed in this presentation are those of the authors and not necessarily those of NICE. Guideline is available from:. Facilitator Background Materials. Review these slides prior to using these materials. Introduction to Training Materials. These training materials . May need to be modified for use if national guidelines do not align with WHO guidance as of March 2022. PrEP. ) Use During Sexual Events by Sexual Minority Men in Canada’s Three Largest Metropolitan Areas. Nathan J. Lachowsky. 1,2,3*. , Cui Z. 3. , . Bacani. N. 3. , Sang JM. 3,4. , Lal A. 3. , Messier-Peet M. use of . antibiotic. . prophylaxis. in . surgery. . at. Bach Mai Hospital. Patrick De Mol. Projet de pharmacie . clinique. Bach Mai . Hospital. , Hanoi, . Vitenam. – 12 . November. 2015. Importance of .